The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions. If you have any queries about specific SPCs on our website then please e-mail info@hpra.ie


Erdotin 300 mg capsules



Galen Pharma Ireland LimitedPA22680/004/001

Main Information

Trade NameErdotin 300 mg capsules
Active SubstancesErdosteine
Dosage FormCapsule, hard
Licence HolderGalen Pharma Ireland Limited
Licence NumberPA22680/004/001

Group Information

ATC CodeR05CB Mucolytics
R05CB15 erdosteine

Status

License statusAuthorised
Licence Issued13/10/2006
Legal statusProduct subject to prescription which may be renewed (B)
Supply StatusSupply through pharmacies only
Advertising StatusAdvertising to healthcare professionals only
Conditions of Licence
Marketing StatusMarketed

Documents

Summary of Product CharacteristicsPDF Version
Package LeafletPDF Version
Public Assessment ReportNo document available
« Back